OD Esocover 30mg/40mg Capsule SR is a combination pharmaceutical formulation containing Domperidone 30mg and Esomeprazole 40mg designed for sustained release. Domperidone is a peripheral dopamine D2 receptor antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms of nausea and vomiting. Esomeprazole, a proton pump inhibitor (PPI), acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, leading to a significant reduction in gastric acid secretion. This dual-action capsule is indicated for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, and other acid-related disorders where delayed gastric emptying and acid hypersecretion coexist. The sustained-release formulation ensures prolonged therapeutic plasma concentrations, enhancing efficacy and improving patient compliance by reducing dosing frequency. OD Esocover is contraindicated in patients with known hypersensitivity to either component and should be used cautiously in individuals with underlying cardiac conditions due to Domperidone’s potential to prolong the QT interval. Common adverse effects may include headache, dry mouth, and abdominal discomfort. Clinical monitoring is recommended to optimize therapy and minimize risks.